UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000000824
Receipt number R000000986
Scientific Title Trial for Cerebellar Ataxia Rehabilitation
Date of disclosure of the study information 2007/09/12
Last modified on 2011/09/12 09:34:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Trial for Cerebellar Ataxia Rehabilitation

Acronym

CAR trial

Scientific Title

Trial for Cerebellar Ataxia Rehabilitation

Scientific Title:Acronym

CAR trial

Region

Japan


Condition

Condition

Spinocerebellar degeneration

Classification by specialty

Neurology Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To test if intensive rehabilitation improve ataxia and its related disability in patients with cerebellar ataxia.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Phase II


Assessment

Primary outcomes

SARA (Scale for the assessment and rating of Ataxia
FIM (Functional Independence Measure)

Key secondary outcomes

Gait speed
Cadence
Functional Ambulation Category (FAC)


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -investigator(s) and assessor(s) are blinded

Control

No treatment

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Physical therapy and Occupational therapy followed by Observation

Interventions/Control_2

Observation followed by Physical therapy and Occupational therapy

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with spinocerebellar degeneration with isolated cerebellar symptoms (SCA6,16qADC or LCCA)
No cognitive impairment (MMSE>=24)
Ambulatory or ambulatory with assistance of one person

Key exclusion criteria

Prior stroke, pain with arthritis during gait, dyspnea or chest pain induced by a low intensity exercise, poor endurance due to cardiopulmonary diseases

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masatoyo Nishizawa

Organization

Brain Research Institute, Niigata University

Division name

Department of Neurology

Zip code


Address

1-757, Asahi-machi-dori, Niigata, Niigata, Japan 951-8585

TEL

025-227-0663

Email



Public contact

Name of contact person

1st name
Middle name
Last name Mizuki Ito

Organization

Nagoya University Graduate School of Medicine

Division name

Department of Neurology

Zip code


Address

65 Tsuruma-Cho, Showa-Ku,Nagoya, 466-8550, Japan

TEL

052-744-2391

Homepage URL


Email

itohm@med.nagoya-u.ac.jp


Sponsor or person

Institute

Brain Research Institute, Niigata University

Institute

Department

Personal name



Funding Source

Organization

Grant-in-Aid for "the Research Committee for Ataxic Diseases" of the Research on Measures for Intractable Diseases

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2007 Year 09 Month 12 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

Short-term benefit of intensive rehabilitation was evident in patients with degenerative cerebellar diseases. Although the functional status tended to decline to the baseline level within 24 weeks, saving of the functional gains was seen in more than half of the patients at 24 weeks after the intervention.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2007 Year 08 Month 08 Day

Date of IRB


Anticipated trial start date

2007 Year 09 Month 01 Day

Last follow-up date

2010 Year 06 Month 01 Day

Date of closure to data entry

2010 Year 06 Month 01 Day

Date trial data considered complete

2010 Year 07 Month 01 Day

Date analysis concluded

2011 Year 06 Month 01 Day


Other

Other related information

Miyai I, Ito M, Hattori N, Mihara M, Hatakenaka M, Yagura H, Sobue G, Nishizawa M. Cerebellar Ataxia Rehabilitation (CAR) trial in degenerative cerebellar diseases. Neurorehabilitation and Neural Repair 2011, in press.


Management information

Registered date

2007 Year 09 Month 12 Day

Last modified on

2011 Year 09 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000986


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name